Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.45−0.13 (-22.18%)
Close on Nov 13, 2026Market cap $930.08KP/E –Yield –
Curis cash
Cash and short-term investments held at the end of each period.
Curis's cash was $5.01M at Sep 30, 2026. For fiscal 2025 it was $5.10M, down 74.5% from the year before. Over ten years it grew -24.3% a year on average. The highest annual figure on record is $183.10M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10M | -74.5% |
| FY2024 | Dec 31, 2024 | $20.00M | -64.5% |
| FY2023 | Dec 31, 2023 | $56.30M | -34.2% |
| FY2022 | Dec 31, 2022 | $85.60M | -38.8% |
| FY2021 | Dec 31, 2021 | $139.80M | -23.6% |
| FY2020 | Dec 31, 2020 | $183.10M | +793.2% |
| FY2019 | Dec 31, 2019 | $20.50M | -15.6% |
| FY2018 | Dec 31, 2018 | $24.30M | -59.6% |
| FY2017 | Dec 31, 2017 | $60.20M | +35.3% |
| FY2016 | Dec 31, 2016 | $44.50M | -45.9% |
| FY2015 | Dec 31, 2015 | $82.19M | +65.2% |
| FY2014 | Dec 31, 2014 | $49.75M | -14.5% |
| FY2013 | Dec 31, 2013 | $58.18M | +4.8% |
| FY2012 | Dec 31, 2012 | $55.54M | +47.3% |
| FY2011 | Dec 31, 2011 | $37.72M | -6.6% |
| FY2010 | Dec 31, 2010 | $40.38M | +455.0% |
| FY2009 | Dec 31, 2009 | $7.28M | -28.4% |
| FY2008 | Dec 31, 2008 | $10.16M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.01M | -44.9% |
| Q2 FY2026 | Jun 30, 2026 | $5.10M | -49.5% |
| Q1 FY2026 | Mar 31, 2026 | $15.00M | -26.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.10M | -74.5% |
| Q3 FY2025 | Sep 30, 2025 | $9.10M | -56.5% |
| Q2 FY2025 | Jun 30, 2025 | $10.10M | -64.4% |
| Q1 FY2025 | Mar 31, 2025 | $20.30M | -50.1% |
| Q4 FY2024 | Dec 31, 2024 | $20.00M | -64.5% |
| Q3 FY2024 | Sep 30, 2024 | $20.90M | -69.5% |
| Q2 FY2024 | Jun 30, 2024 | $28.40M | -55.3% |
| Q1 FY2024 | Mar 31, 2024 | $40.70M | -43.3% |
| Q4 FY2023 | Dec 31, 2023 | $56.30M | -34.2% |
| Q3 FY2023 | Sep 30, 2023 | $68.50M | -30.6% |
| Q2 FY2023 | Jun 30, 2023 | $63.50M | -40.8% |
| Q1 FY2023 | Mar 31, 2023 | $71.80M | -40.5% |
| Q4 FY2022 | Dec 31, 2022 | $85.60M | -38.8% |
| Q3 FY2022 | Sep 30, 2022 | $98.70M | -34.1% |
| Q2 FY2022 | Jun 30, 2022 | $107.20M | -33.3% |
| Q1 FY2022 | Mar 31, 2022 | $120.70M | -28.3% |
| Q4 FY2021 | Dec 31, 2021 | $139.80M | -23.6% |
| Q3 FY2021 | Sep 30, 2021 | $149.80M | +534.7% |
| Q2 FY2021 | Jun 30, 2021 | $160.70M | +580.9% |
| Q1 FY2021 | Mar 31, 2021 | $168.40M | +1247.2% |
| Q4 FY2020 | Dec 31, 2020 | $183.10M | +793.2% |
| Q3 FY2020 | Sep 30, 2020 | $23.60M | -15.7% |
| Q2 FY2020 | Jun 30, 2020 | $23.60M | -33.1% |
| Q1 FY2020 | Mar 31, 2020 | $12.50M | -70.8% |
| Q4 FY2019 | Dec 31, 2019 | $20.50M | -15.6% |
| Q3 FY2019 | Sep 30, 2019 | $28.00M | -9.1% |
| Q2 FY2019 | Jun 30, 2019 | $35.30M | -12.6% |
| Q1 FY2019 | Mar 31, 2019 | $42.80M | -11.8% |
| Q4 FY2018 | Dec 31, 2018 | $24.30M | -59.6% |
| Q3 FY2018 | Sep 30, 2018 | $30.80M | -55.5% |
| Q2 FY2018 | Jun 30, 2018 | $40.40M | -20.8% |
| Q1 FY2018 | Mar 31, 2018 | $48.50M | -20.2% |
| Q4 FY2017 | Dec 31, 2017 | $60.20M | +35.3% |
| Q3 FY2017 | Sep 30, 2017 | $69.20M | – |
| Q2 FY2017 | Jun 30, 2017 | $51.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $60.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $44.50M | – |
See a number that looks wrong?